Recurrent UTIs after menopause: why they happen and how to prevent them
Urinary tract infections (UTIs) often become more frequent after menopause, partly because lower estrogen changes the tissues of the vagina and urinary tract. Vaginal estrogen is the best-supported way to prevent repeat infections in peri- and postmenopausal women and is recommended in US and Canadian urology guidelines.
Get medical help the same day if a UTI comes with fever or shivering, back or side pain, blood in your urine, vomiting, or new confusion, as these can mean a kidney infection. See a doctor or pharmacist for any suspected UTI, and ask about prevention after two in six months or three in a year.
What counts as recurrent UTIs
A UTI is an infection of the bladder (cystitis) or, less often, the kidneys. Common signs are burning when you pee, needing to go often or urgently, cloudy or strong-smelling urine, and lower tummy pain.7
Doctors call UTIs recurrent when there are two confirmed infections in six months, or three in a year.1 US and Canadian guidelines advise a urine test and culture with each episode of symptoms.1,8 This confirms the infection and helps pick the right antibiotic.1
In older women, a UTI does not always cause typical bladder symptoms. Sudden confusion over a few days can be the main sign, and it can be mistaken for dementia.7
Why UTIs after menopause are more common
Menopause is a known risk factor for UTIs.7 After menopause, lower estrogen changes the tissues of the vagina and urinary tract. These changes are part of genitourinary syndrome of menopause (GSM), which often goes along with repeat UTIs.3
Other risk factors include diabetes, a weakened immune system and not drinking enough.7 Kidney stones or anything else that blocks the urinary tract also raise risk.7
Vaginal estrogen for UTI prevention
Three urology societies from the US and Canada (AUA, CUA and SUFU) publish a joint guideline.1 It recommends vaginal estrogen for peri- and postmenopausal women with recurrent UTIs, unless there is a reason not to use it.1 The 2025 amendment to the guideline did not change this advice.2
A Cochrane review found two small trials in which vaginal estrogen cut the number of women who got UTIs.4 One was placebo-controlled and one was open-label.3 In one, an estriol cream reduced repeat UTIs by about 75%; in the other, an estradiol vaginal ring reduced them by about 36%.3 The trials were small and had some weaknesses, so the exact size of the benefit is uncertain.3
Estrogen tablets taken by mouth did not prevent UTIs in four trials with nearly 2,800 women.4 So systemic HRT is not a substitute for vaginal treatment if UTI prevention is the goal.
Vaginal estrogen is prescribed as creams, tablets or rings, and the products available differ by country.3 Side effects can include vaginal irritation, discharge or spotting.4 Any unexpected bleeding should be reported to a doctor.3 If you have had breast cancer, discuss options with your cancer team.
Other prevention options: cranberry, D-mannose and more
Cranberry. A 2023 Cochrane review looked at 50 trials.5 It found cranberry products probably lower the risk of UTIs in women with repeat infections, by roughly a quarter.5 They did not clearly help older people in care homes.5 The 2025 guideline update says doctors should offer cranberry as an option for prevention.2
D-mannose. This sugar is sold as a supplement. In a 2024 UK trial of 598 women with recurrent UTIs, D-mannose did no better than a dummy pill over six months.6 The 2025 guideline update says doctors should tell women that D-mannose on its own may not prevent UTIs.2
Methenamine hippurate. This non-antibiotic medicine makes urine less friendly to bacteria. The 2025 guideline update added a new, conditional recommendation that doctors may offer it for prevention.2 The main evidence is a 2022 UK trial. In that trial, methenamine was not clearly worse than daily low-dose antibiotics at preventing UTIs.8 The evidence is graded as low (grade C), and it is a prescription medicine in some countries, so ask a doctor whether it suits you.2
Probiotics. The guideline panel was unable to recommend probiotics (Lactobacillus) for prevention. Some early trials of vaginal probiotics looked promising, but the evidence is not yet strong enough.8
Preventive antibiotics. Doctors may offer these after talking through the risks and benefits, including side effects and antibiotic resistance.1 The guideline also stresses non-antibiotic options, to limit resistance.8
Everyday habits. The guideline says doctors may suggest drinking more water if you drink less than about 1.5 liters (50 oz) a day.2 Other common advice includes not delaying peeing, emptying your bladder after sex and wiping front to back, though these have little trial evidence.7
What helps: options rated
| Option | Evidence | What the research shows |
|---|---|---|
| Vaginal estrogen | Recommended in AUA/CUA/SUFU guidelines for peri- and postmenopausal women with recurrent UTIs.1,2 Supported by two small trials, one of them placebo-controlled.3,4 | |
| Preventive antibiotics | Guidelines say doctors may offer them after discussing risks and benefits, including resistance and side effects.1 A prescription decision for your doctor. | |
| Cranberry products | A 2023 Cochrane review found they probably reduce UTIs in women with repeat infections, but not clearly in older people in care homes.5 The 2025 guideline says doctors should offer them as an option.2 | |
| Drinking more water | The 2025 guideline update says more water may be offered for women drinking under about 1.5 liters a day.2 | |
| Methenamine hippurate (prescription) | One good-sized 2022 trial found it was not clearly worse than daily antibiotics, and the 2025 guideline says doctors may offer it. The recommendation is conditional.2,8 | |
| D-mannose | A large 2024 trial found no benefit over placebo, and the 2025 guideline says it may not be effective on its own.2,6 | |
| Oral (systemic) estrogen | Did not prevent UTIs in four trials, unlike vaginal estrogen.4 | |
| Probiotics (Lactobacillus) | Early trials of vaginal probiotics looked promising, but the guideline panel could not recommend them.8 |
Ratings explained: how we rate. Always talk to a doctor or pharmacist before starting a medicine or supplement.
Related
Sources
- Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline, American Urological Association (2019, reviewed 2022)
- Updates to recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline (2025 amendment), statement summary, American Urological Association (2025)
- Vaginal estrogens for recurrent UTIs, Refills, BC Provincial Academic Detailing Service, Government of British Columbia (December 2025)
- Perrotta C et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women, Cochrane (2008)
- Williams G et al. Cranberries for preventing urinary tract infections, Cochrane (2023)
- D-mannose found to be ineffective for prevention of recurrent UTI (Hayward et al., JAMA Internal Medicine 2024), Urology Times
- Urinary tract infections (UTIs), Age UK
- Ackerman AL et al. Updates to recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline (2025), Journal of Urology 2026;215:3-12 (full-text copy, BINASSS)